Technologies
Camurus is a company focused on the development of lipid-liquid crystals as a novel drug delivery route. These structures are well-defined three dimensional formations consisting of lipophilic and hydrophilic domains that can be either interconnected or isolated depending on the environmentally induced phase conditions. These unique crystalline structures offer a unique way of encapsulating and transporting Active pharmaceutical ingredients, such as small molecules, peptides and proteins through the body. The structures also allow for the use of controlled release preventing the degradation of fragile molecules before they reach the therapeutic target, a serious issue for amino-acid based drugs. These factors combine to allow for high drug payloads and offer an exciting new alternative to traditional drug delivery systems. In addition, the controlled release pattern allows a greater amount of drug to be delivered, without the risk of potentially toxic levels in the blood.
Camurus’ gel technology is known as FluidCrystal and their nanoparticle systems are known as FluidCrystal Nano-Particles. The three varieties of Fluid Crystal NP carriers are Cubosomes, Hexosomes, and Flexosomes. Camurus’ technologies are applicable in oral, topical and parenteral drug delivery.
Read more about this topic: Camurus